Global proteomic analysis of post-mortem anterior temporal lobe samples from
schizophrenia patients and non-schizophrenia individuals was performed using stable …

Schizophrenia is an incurable and debilitating mental disorder that may affect up to 1% of
the world population. Morphological, electrophysiological, and neurophysiological studies …

Schizophrenia is a complex disease, likely to be caused by a combination of serial
alterations in a number of genes and environmental factors. The dorsolateral prefrontal …

Abnormalities in the size and activity of the insular cortex (IC), a brain region involved in
auditory hallucinations and language, have been previously found in brain imaging studies …

Despite intense scientific efforts, the neuropathology and pathophysiology of schizophrenia
are poorly understood. Proteomic studies, by testing large numbers of proteins for …

Schizophrenia is a chronic disease characterized by the impairment of mental functions with
a marked social dysfunction. A quantitative proteomic approach using iTRAQ labeling and …

Despite all the efforts regarding the treatment of schizophrenia patients and the growing
advances in molecular diagnosis studies, the biochemical basis of this debilitating psychotic …

Schizophrenia is a multifactorial disease in both clinical and molecular terms. Thus,
depicting the molecular aspects of the disease will contribute to the understanding of its …

Schizophrenia is a chronic and incurable neuropsychiatric disorder that affects about one
percent of the world population. The proteomic characterization of the synaptosome fraction …

Objectives. Proteome analysis has emerged as a promising strategy to the identification of
potential biomarkers and to further confirm the importance of certain pathways in the …